In the latest trading session, 12.23 million 180 Life Sciences Corp (NASDAQ:ATNF) shares changed hands as the company’s beta touched 0. With the company’s most recent per share price at $2.34 changing hands around $0.47 or 25.13% at last look, the market valuation stands at $4.63M. ATNF’s current price is a discount, trading about -658.55% off its 52-week high of $17.75. The share price had its 52-week low at $1.16, which suggests the last value was 50.43% up since then. When we look at 180 Life Sciences Corp’s average trading volume, we note the 10-day average is 0.16 million shares, with the 3-month average coming to 2.01 million.

180 Life Sciences Corp (NASDAQ:ATNF) trade information

Instantly ATNF is in green as seen in intraday trades today. With action 28.57%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -42.31%, with the 5-day performance at 28.57% in the green. However, in the 30-day time frame, 180 Life Sciences Corp (NASDAQ:ATNF) is 4.00% up. Looking at the short shares, we see there were 0.14 million shares sold at short interest cover period of 0.03 days.

ATNF Dividends

180 Life Sciences Corp is expected to release its next quarterly earnings report in January.

180 Life Sciences Corp (NASDAQ:ATNF)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 4.34% of 180 Life Sciences Corp shares while 3.45% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 3.61%.

Among Mutual Funds, the top two as of Oct 31, 2024 were Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund. With 4.65 shares estimated at $10785.0 under it, the former controlled 0.24% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.13% of the shares, roughly 2.52 shares worth around $5848.0.